Story

LyondellBasell Stock Outpaces Dow Amid Divergent Recovery Bets

ENTHMSVIIDZHZH-TWJAKOHI
Aug 25, 20262 min read
LyondellBasell Stock Outpaces Dow Amid Divergent Recovery Bets
Text size
Background

Shares of LyondellBasell (LYB) have significantly outperformed chemical industry peer Dow (DOW) this year, reflecting investor expectations for a more robust earnings recovery. An analysis by Investing.com shows LyondellBasell's stock has gained 45.6% year-to-date, while Dow has risen 30.4%, as of August 25, 2026.

Valuation Gap Widens

The performance gap is mirrored in the companies' forward-looking valuations, even as both navigate a deep cyclical downturn. According to the analysis, which uses fundamental data as of June 30, 2026, LyondellBasell trades at a more attractive valuation on several key metrics.

  • Forward P/E Ratio: LYB at 7.1x versus DOW at 12.6x.
  • Free Cash Flow Yield: LYB at 7.7% compared to DOW's 6.6%.
  • Estimated Fair Value Upside: The analysis suggests a 16.2% potential upside for LYB, compared to 9.2% for DOW.

This valuation discount for LyondellBasell suggests the market is pricing in a faster and more substantial rebound in its profitability.

Navigating a Cyclical Trough

Sample IUX Markets – In-articleAd

Both chemical giants have experienced significant earnings erosion amid challenging market conditions. Both companies posted net losses in fiscal year 2025 and have seen their trailing price-to-earnings ratios turn negative. The downturn has been severe, with Dow's EBITDA falling 75% from $10.9 billion in 2021 to $2.7 billion in 2025. LyondellBasell saw a similar 74% drop, from $8.6 billion to $2.2 billion over the same period.

However, LyondellBasell appears to have weathered the downturn with more resilient fundamentals. It maintains a superior gross profit margin of 12.9% versus Dow's 9.8% and reported a smaller net loss of -$0.8 billion in 2025, compared to Dow's -$2.6 billion loss, according to the source data.

Contrasting Investment Cases

The data presents two distinct scenarios for investors considering the chemical sector's recovery. LyondellBasell's case is built on its stronger current profitability, higher free cash flow generation, and a more compelling forward valuation. Its less negative Return on Equity (ROE) of -2.3% compared to Dow's -7.9% further highlights its relative operational stability.

Conversely, Dow offers a slightly higher dividend yield of 4.5% versus LyondellBasell's 4.2% and trades at a deeper discount to its book value. The primary bull case for Dow hinges on a broad-based recovery in chemical demand. Its historically higher operating leverage could enable a sharper and more pronounced earnings rebound if the industry cycle turns decisively positive.

Read next

More on Stocks
Back to latest news

LATEST